Claros Mortgage Trust, Inc. (CMTG)

On our desk, the reaction to CMTG's Q2 2026 print has been brutal. Taking a $255.4 million GAAP net loss and a $208.8 million CECL reserve hit completely changes the risk narrative. Even though management is pushing hard on loan and REO resolutions—chipping in $482 million this quarter—the sheer scale of credit provisioning leaves market participants questioning where the true valuation floor sits. We are advising clients to watch how pro forma liquidity scales past the $168 million mark before touching the equity.

Watching the net debt-to-equity ratio drop from 2.0x to 1.7x post-July resolutions is a positive operational signal, but the fundamental book value compression down to $8.58 per share cannot be ignored. The massive CECL coverage—now sitting at 16.9% of the unpaid principal balance and 32.0% on risk-rated 5 loans—shows that management is finally ripping the band-aid off legacy distress. However, until distibutable losses (prior to realized gains/losses at $10.5 million) normalize, this remains a high-beta trade for distressed specialists only.

From a credit underwriting perspective, CMTG's Q2 2026 disclosures underscore the hazards of commercial real estate debt strategies in a high-rate, low-liquidity environment. Analysts need to look closely at the $29.6 million of losses incurred strictly from reclassifying real estate owned assets to held-for-sale. That realization metric tells me that historical carrying values were overly optimistic. When stress-testing these portfolios, one must factor in steep recovery haircuts, mirroring the 90% gross recovery seen on previous watchlist loan sales.

The sentiment divergence on CMTG between bullish retail investors and bearish institutional shops like KBW highlights the severe pain of commercial mortgage REITs. While UBS previously maintained a more constructive stance, the sheer magnitude of the $208.8 million CECL provision in Q2 2026 validates the structural shorts. Unless regular-way repayments—such as the $223 million recorded this quarter—accelerate significantly faster than expected credit deterioration, the path of least resistance for the share price remains downward.

Hedging with put spreads around CMTG has been an active strategy on our options desk, especially after KBW downgraded the stock to 'Underperform' with a $2.25 price target earlier in the cycle. With the equity trading down near $1.73 and market cap hovering around $244.1 million, the market is aggressively pricing in further asset impairments. The Q2 GAAP loss of $1.81 per share blew past even conservative downside estimates, rendering historical forward multiples practically useless.